Volume 19, 2015

Sign On

Volume 19, 2015 CD
Six back issues from 2015 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 19 No. 1	January/February 2015	Volume 19, Number 1
Vol. 19 No. 2	March/April 2015	Volume 19, Number 2
Vol. 19 No. 3	May/June 2015	Volume 19, Number 3
Vol. 19 No. 4	July/August 2015	Volume 19, Number 4
Vol. 19 No. 5	September/October 2015	Volume 19, Number 5
Vol. 19 No. 6	November/December 2015	Volume 19, Number 6

Volume 19, 2015 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 19, 2015 CD ARTICLES
PreScription: 2014 in Review	Vol. 19 No. 1	4
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review	Vol. 19 No. 1	6
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists	Vol. 19 No. 1	14
Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding	Vol. 19 No. 1	18
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance	Vol. 19 No. 1	30
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1	Vol. 19 No. 1	38
Quality Control Analytical Methods: Refractive Index	Vol. 19 No. 1	43
Basics of Sterile Compounding: Aseptic Processing	Vol. 19 No. 1	49
Basics of Compounding: The Revised "Not to Compound List"	Vol. 19 No. 1	57
Calculations	Vol. 19 No. 1	59
Atenolol 25-, 50-, or 100-mg Capsules	Vol. 19 No. 1	60
Azathioprine 50-mg Capsules	Vol. 19 No. 1	61
Cisplatin 1-mg/mL Injection	Vol. 19 No. 1	62
Daunorubicin 5-mg/mL Injection	Vol. 19 No. 1	63
Erythromycin 50-mg/mL Injection	Vol. 19 No. 1	64
Hydralazine Hydrochloride 20-mg/mL Injection	Vol. 19 No. 1	65
Hydroxychloroquine Sulfate 200-mg Capsules	Vol. 19 No. 1	66
Lidocaine Hydrochloride 4% Topical Solution	Vol. 19 No. 1	67
Mupirocin 2% Ointment	Vol. 19 No. 1	68
Phentolamine Mesylate 5-mg/mL Injection	Vol. 19 No. 1	69
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration	Vol. 19 No. 1	70
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions	Vol. 19 No. 1	73
Stability of Suspensions: Theoretical and Practical Considerations before Compounding	Vol. 19 No. 1	78
PostScription: Pharmacists Advancing Toward Provider Status	Vol. 19 No. 1	86
PreScription: Some of the Best Sermons are Lived, not Preached!	Vol. 19 No. 2	92
New England Compounding Center Indictment	Vol. 19 No. 2	94
Standing Together Fixing the Drug Quality and Security Act	Vol. 19 No. 2	104
Standarized Compounding: The Importance of Doing it the Same Way Every Time	Vol. 19 No. 2	109
Bedside Manner: Not Just for Doctors Anymore	Vol. 19 No. 2	115
Quality Assurance and Quality Control, Part 1	Vol. 19 No. 2	121
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing	Vol. 19 No. 2	127
Calculations	Vol. 19 No. 2	140
Acne Scrub	Vol. 19 No. 2	142
Aminohippurate Sodium 200-mg/mL Injection	Vol. 19 No. 2	143
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection	Vol. 19 No. 2	144
Heparin 335-United/Gram Gel-Cream	Vol. 19 No. 2	145
L-Cysteine Hydrochloride 50-mg/mL Injection	Vol. 19 No. 2	146
Morrhuate Sodium 5% Injection	Vol. 19 No. 2	147
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution	Vol. 19 No. 2	148
Pancuronium Bromide 1-mg/mL Injection	Vol. 19 No. 2	149
Physostigmine Salicylate 1-mg/mL Injection	Vol. 19 No. 2	150
Trypan Blue 0.06% Ophthalmic Solution	Vol. 19 No. 2	151
Transdermal Delivery of Nisoldipine: Refinement of Vehicles	Vol. 19 No. 2	152
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations	Vol. 19 No. 2	161
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time	Vol. 19 No. 2	167
PostScription: What's Your Patient Care Story?	Vol. 19 No. 2	174
PreScription: 2015 Student Pharmacist Compounding Competition	Vol. 19 No. 3	180
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities	Vol. 19 No. 3	182
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy	Vol. 19 No. 3	195
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls	Vol. 19 No. 3	205
IACP Says: "Fix DQSA"	Vol. 19 No. 3	212
Quality Assurance and Quality Control, Part 2	Vol. 19 No. 3	215
Basics of Compounding: Compounding with Silicones	Vol. 19 No. 3	223
Basics of Sterile Compounding: Contamination Control	Vol. 19 No. 3	232
Calculations	Vol. 19 No. 3	240
Atropine Sulfate 1% Ophthalmic Solution	Vol. 19 No. 3	242
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution	Vol. 19 No. 3	243
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches	Vol. 19 No. 3	244
Phenazopyridine Hydrochloride 200-mg Capsules	Vol. 19 No. 3	245
Physostigmine Salicylate 1-mg/mL Injection	Vol. 19 No. 3	246
Scopolamine Hydrobromide -.4-mg/mL Injection	Vol. 19 No. 3	247
Stability of Metronidazole Suspensions	Vol. 19 No. 3	248
Protocol of Blood Serum Eye Drops	Vol. 19 No. 3	252
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials	Vol. 19 No. 3	261
PreScription: Potpourri of Opinions…From Many	Vol. 19 No. 4	266
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom	Vol. 19 No. 4	268
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles	Vol. 19 No. 3	268
PostScription: Opportunities to Change the Pharmacy Landscape	Vol. 19 No. 3	271
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2	Vol. 19 No. 4	280
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity	Vol. 19 No. 4	289
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review	Vol. 19 No. 4	295
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Vol. 19 No. 4	303
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units	Vol. 19 No. 4	307
Basics of Compounding: The "Negative" List	Vol. 19 No. 4	311
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing	Vol. 19 No. 4	315
Calculations	Vol. 19 No. 4	322
Ammonium Molybdate 25-mcg/mL Injection	Vol. 19 No. 4	324
Balsam Peru, Castor Oil, and Trypsin Ointment	Vol. 19 No. 4	325
Benzonatate 100-mg Capsules	Vol. 19 No. 4	326
Chloroquine Phosphate 250-mg Capsules	Vol. 19 No. 4	327
Cytarabine 50-mg/mL Injection	Vol. 19 No. 4	328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection	Vol. 19 No. 4	329
Oxytocin 10-units/mL Injection	Vol. 19 No. 4	330
Phytonadione 2-mg/mL Injection	Vol. 19 No. 4	331
Proparacaine Hydrochloride 0.5% Ophthalmic Solution	Vol. 19 No. 4	332
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg	Vol. 19 No. 4	333
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters	Vol. 19 No. 4	334
Stability of Prednisone in Oral Mix Suspending Vehicle	Vol. 19 No. 4	337
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals	Vol. 19 No. 4	340
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes	Vol. 19 No. 4	344
PostScription: APhA2015: You Spoke, We Listened, and What a Success!	Vol. 19 No. 4	348
PreScription: Failure or Success?	Vol. 19 No. 5	354
Novel Approaches to Topical Psoriasis Therapy	Vol. 19 No. 5	357
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries	Vol. 19 No. 5	367
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding	Vol. 19 No. 5	375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists	Vol. 19 No. 5	377
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations	Vol. 19 No. 5	383
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1	Vol. 19 No. 5	389
Sterile Filtration	Vol. 19 No. 5	393
Calculations	Vol. 19 No. 5	402
Aminocaproic Acid 250-mg/mL Oral Solution	Vol. 19 No. 5	404
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel	Vol. 19 No. 5	405
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment	Vol. 19 No. 5	406
Nimodipine 3-mg/mL Oral Solution	Vol. 19 No. 5	407
Ofloxacin 0.3% Otic Solution	Vol. 19 No. 5	408
Povidone Iodine 10% Cold Sore Paint	Vol. 19 No. 5	409
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion	Vol. 19 No. 5	410
Vehicle for Oral Solution (National Formulary 26)	Vol. 19 No. 5	411
Vehicle for Oral Solution, Sugar Free (National Formulary 26)	Vol. 19 No. 5	412
Vehicle for Oral Suspension (National Formulary 26)	Vol. 19 No. 5	413
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules	Vol. 19 No. 5	414
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF	Vol. 19 No. 5	420
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures	Vol. 19 No. 5	428
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers	Vol. 19 No. 5	432
PostScription: Progress Report: Provider Status Continues to Gain Strength!	Vol. 19 No. 5	437
PreScription: The Documented Past and the Exciting Future	Vol. 19 No. 6	442
Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding"	Vol. 19 No. 6	444
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance	Vol. 19 No. 6	449
Applying Quality of Design Concepts to Pharmacy Compounding	Vol. 19 No. 6	453
Root Cause Analysis, Part 1: Nonsterile Compounding	Vol. 19 No. 6	465
Basic Principles of Lyophilization, Part 1	Vol. 19 No. 6	471
Mixing in a Compounding Pharmacy in the 21st Century	Vol. 19 No. 6	479
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Vol. 19 No. 6	487
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems	Vol. 19 No. 6	491
Calculations	Vol. 19 No. 6	502
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules	Vol. 19 No. 6	504
Cefepime Hydrochloride 100-mg/mL Injection	Vol. 19 No. 6	505
Cefotaxime 100-mg/mL Injection	Vol. 19 No. 6	506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved	Vol. 19 No. 6	507
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate	Vol. 19 No. 6	508
Estradiol Valerate 40-mg/mL in Oil Injection	Vol. 19 No. 6	509
Levetiracetam 100-mg/mL Injection (Concentrate)	Vol. 19 No. 6	510
Memantine Hydrochloride Capsules	Vol. 19 No. 6	511
Mupirocin 2% Nasal Ointment	Vol. 19 No. 6	512
Propranolol Hydrochloride Capsules	Vol. 19 No. 6	513
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States	Vol. 19 No. 6	514
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment	Vol. 19 No. 6	521
PostScription: Pharmacy Fellowship Program: Building a Stronger Profession	Vol. 19 No. 6	525